We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-2.42%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$5.17B
AUM Growth
-$545M
Cap. Flow
-$309M
Cap. Flow %
-5.98%
Top 10 Hldgs %
66.94%
Holding
136
New
4
Increased
19
Reduced
43
Closed
14

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$260M
2
FRC
First Republic Bank
FRC
+$125M
3
BABA icon
Alibaba
BABA
+$9.42M
4
BIDU icon
Baidu
BIDU
+$4.48M
5
INCY icon
Incyte
INCY
+$3.06M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$261M
2
BFH icon
Bread Financial
BFH
+$148M
3
ST icon
Sensata Technologies
ST
+$130M
4
HD icon
Home Depot
HD
+$54.4M
5
WFC icon
Wells Fargo
WFC
+$43.6M

Sector Composition

Rank Sector Weight
1 Financials 26.08%
2 Healthcare 25.94%
3 Consumer Discretionary 13.86%
4 Communication Services 13.8%
5 Consumer Staples 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZLTQ
51
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$4.07M 0.08%
150,000
– –
CPHD
52
DELISTED
Cepheid Inc
CPHD
$3.92M 0.08%
117,400
– –
RLYP
53
DELISTED
RELYPSA INC COM
RLYP
$3.63M 0.07%
268,000
-25,000
-9% -$425K
SUPN icon
54
Supernus Pharmaceuticals
SUPN
$2.73B
$3.63M 0.07%
238,000
– –
PODD icon
55
Insulet
PODD
$11.7B
$3.58M 0.07%
108,000
-40,000
-27% -$1.26M
ITCI
56
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.49M 0.07%
125,500
+1,500
+1% +$50K
CHRS icon
57
Coherus Oncology
CHRS
$222M
$3.15M 0.06%
148,500
+2,500
+2% +$41K
DXCM icon
58
DexCom
DXCM
$29.2B
$3.08M 0.06%
181,700
-18,000
-9% -$301K
DVAX
59
DELISTED
Dynavax Technologies
DVAX
$3.08M 0.06%
159,962
-24,400
-13% -$493K
INCY icon
60
Incyte
INCY
$25.4B
$2.97M 0.06%
+41,000
New +$3.06M
INNL
61
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$2.53M 0.05%
295,184
– –
RARE icon
62
Ultragenyx Pharmaceutical
RARE
$2.51B
$2.53M 0.05%
40,000
– –
ZVRA icon
63
Zevra Therapeutics
ZVRA
$558M
$2.39M 0.05%
10,313
– –
ONCE
64
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.37M 0.05%
80,400
+1,780
+2% +$56.1K
AERI
65
DELISTED
Aerie Pharmaceuticals
AERI
$2.33M 0.05%
192,006
– –
SPNC
66
DELISTED
Spectranetics Corp
SPNC
$2.32M 0.04%
159,956
-59,000
-27% -$817K
IONS icon
67
Ionis Pharmaceuticals
IONS
$9.09B
$2.21M 0.04%
54,500
-21,560
-28% -$876K
KITE
68
DELISTED
Kite Pharma, Inc.
KITE
$2.16M 0.04%
47,000
– –
TTPH
69
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$2.14M 0.04%
23,076
-8,200
-26% -$819K
KERX
70
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.97M 0.04%
421,110
– –
EIX icon
71
Edison International
EIX
$30.5B
$1.93M 0.04%
26,900
– –
ACHC icon
72
Acadia Healthcare
ACHC
$2.6B
$1.93M 0.04%
35,000
-15,000
-30% -$856K
MA icon
73
Mastercard
MA
$497B
$1.89M 0.04%
20,000
-8,000
-29% -$707K
INGR icon
74
Ingredion
INGR
$6.47B
$1.84M 0.04%
17,200
+5,300
+45% +$528K
FIS icon
75
Fidelity National Information Services
FIS
$23.7B
$1.78M 0.03%
28,200
– –
1 2
3
4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q1 2016 Portfolio in Review

As of Q1 2016, C WorldWide Group held 136 positions worth $5.17B, down 9.5% from $5.72B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

C WorldWide Group withdrew a net $309M in Q1 2016, closing 14 positions and reducing 43 holdings. Its most notable exit was American International, an estimated $261M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, C WorldWide Group opened a new position in Incyte worth $2.97M.

  • C WorldWide Group's largest Q1 2016 buy was Incyte: 41,000 shares worth $2.97M.
  • C WorldWide Group added most to Dollar General in Q1 2016, an estimated $260M increase.
  • C WorldWide Group's biggest Q1 2016 reduction was Home Depot, cutting an estimated $54.4M.
  • C WorldWide Group fully exited American International in Q1 2016, selling an estimated $261M.
  • C WorldWide Group's ten largest holdings make up 67% of its $5.17B portfolio in Q1 2016.
  • C WorldWide Group opened 4 new positions and closed 14 in Q1 2016.
  • C WorldWide Group's portfolio value fell 9.5% quarter-over-quarter to $5.17B.

Based on C WorldWide Group's 13F filing for Q1 2016, filed 4 May 2016.